Genetics in pharmacokinetics?
Hartter
Sebastian
S
D000929:Antidepressive Agents, Tricyclic / Q000493:pharmacokinetics* / Q000494:pharmacology; D019389:Cytochrome P-450 CYP2D6 / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D003866:Depressive Disorder / Q000188:drug therapy / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005838:Genotype; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics* / Q000494:pharmacology; D000078785:Mirtazapine; D017374:Paroxetine / Q000493:pharmacokinetics* / Q000494:pharmacology; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide / Q000187:drug effects; D044402:Receptor, Serotonin, 5-HT2A / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics* / Q000494:pharmacology
D000929:Antidepressive Agents, Tricyclic; D019389:Cytochrome P-450 CYP2D6; D008803:Mianserin; D000078785:Mirtazapine; D017374:Paroxetine; D044402:Receptor, Serotonin, 5-HT2A; D017367:Selective Serotonin Reuptake Inhibitors